Abstract

The precise regulation of protein function is essential in biological systems and a key goal in chemical biology and protein engineering. Here, we describe a straightforward method to engineer functional control into the isopeptide bond-forming SpyTag/SpyCatcher protein ligation system. First, we perform a cysteine scan of the structured region of SpyCatcher. Except for two known reactive and catalytic residues, none of these mutations abolish reactivity. In a second screening step, we modify the cysteines with disulfide bond-forming small molecules. Here we identify 8 positions at which modifications strongly inhibit reactivity. This inhibition can be reversed by reducing agents. We call such a reversibly inhibitable SpyCatcher “SpyLock”. Using “BiLockCatcher”, a genetic fusion of wild-type SpyCatcher and SpyLock, and SpyTagged antibody fragments, we generate bispecific antibodies in a single, scalable format, facilitating the screening of a large number of antibody combinations. We demonstrate this approach by screening anti-PD-1/anti-PD-L1 bispecific antibodies using a cellular reporter assay.

The SpyTag/SpyCatcher protein ligation technology is valuable in many applications, but few methods exist for controlling reactivity. Here the authors report a method for controlling SpyCatcher activity via S-thiolation of engineered cysteines, demonstrating the value of their technology for the rapid generation of bispecific antibodies.

Details

Title
Engineered reversible inhibition of SpyCatcher reactivity enables rapid generation of bispecific antibodies
Author
Hentrich, Christian 1 ; Putyrski, Mateusz 1 ; Hanuschka, Hanh 1 ; Preis, Waldemar 1 ; Kellmann, Sarah-Jane 1 ; Wich, Melissa 1 ; Cavada, Manuel 1 ; Hanselka, Sarah 1 ; Lelyveld, Victor S. 2 ; Ylera, Francisco 3   VIAFID ORCID Logo 

 Bio-Rad AbD Serotec GmbH, Neuried, Germany 
 Massachusetts General Hospital, Department of Molecular Biology, Boston, USA (GRID:grid.32224.35) (ISNI:0000 0004 0386 9924); Harvard Medical School, Department of Genetics, Boston, USA (GRID:grid.38142.3c) (ISNI:000000041936754X) 
 Bio-Rad AbD Serotec GmbH, Neuried, Germany (GRID:grid.38142.3c) 
Pages
5939
Publication year
2024
Publication date
2024
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
3080881711
Copyright
© The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.